Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region.

Peirano G, van der Bij AK, Gregson DB, Pitout JD.

J Clin Microbiol. 2012 Feb;50(2):294-9. doi: 10.1128/JCM.06025-11. Epub 2011 Dec 7.

PMID:
22162555
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.

Park SH, Byun JH, Choi SM, Lee DG, Kim SH, Kwon JC, Park C, Choi JH, Yoo JH.

BMC Infect Dis. 2012 Jun 29;12:149.

PMID:
22747570
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.

Peirano G, Costello M, Pitout JD.

Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.

PMID:
20359869
[PubMed - indexed for MEDLINE]
4.

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group.

J Antimicrob Chemother. 2012 Nov;67(11):2612-20. doi: 10.1093/jac/dks278. Epub 2012 Jul 26.

PMID:
22843833
[PubMed - indexed for MEDLINE]
Free Article
5.

Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.

Matsumura Y, Nagao M, Iguchi M, Yagi T, Komori T, Fujita N, Yamamoto M, Matsushima A, Takakura S, Ichiyama S.

Clin Microbiol Infect. 2013 Feb;19(2):161-8. doi: 10.1111/j.1469-0691.2012.03762.x. Epub 2012 Feb 14.

PMID:
22332968
[PubMed - indexed for MEDLINE]
6.

The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S.

Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):513-21. doi: 10.1007/s10096-012-1765-9. Epub 2012 Nov 2.

PMID:
23117265
[PubMed - indexed for MEDLINE]
7.

Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.

Pitout JD, Gregson DB, Campbell L, Laupland KB.

Antimicrob Agents Chemother. 2009 Jul;53(7):2846-51. doi: 10.1128/AAC.00247-09. Epub 2009 Apr 20.

PMID:
19380595
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.

Ha YE, Kang CI, Cha MK, Park SY, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.

Int J Antimicrob Agents. 2013 Nov;42(5):403-9. doi: 10.1016/j.ijantimicag.2013.07.018. Epub 2013 Sep 7.

PMID:
24071027
[PubMed - indexed for MEDLINE]
9.

Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands.

van der Bij AK, Peirano G, Goessens WH, van der Vorm ER, van Westreenen M, Pitout JD.

Antimicrob Agents Chemother. 2011 Jul;55(7):3576-8. doi: 10.1128/AAC.00074-11. Epub 2011 Apr 18.

PMID:
21502612
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.

Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL.

Antimicrob Agents Chemother. 2012 Feb;56(2):618-22. doi: 10.1128/AAC.05753-11. Epub 2011 Nov 28.

PMID:
22123694
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.

Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E.

J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20.

PMID:
23515552
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.

J Antimicrob Chemother. 2009 Jun;63(6):1135-41. doi: 10.1093/jac/dkp122. Epub 2009 Apr 7.

PMID:
19351692
[PubMed - indexed for MEDLINE]
Free Article
13.

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

Díaz MA, Hernández-Bello JR, Rodríguez-Baño J, Martínez-Martínez L, Calvo J, Blanco J, Pascual A; Spanish Group for Nosocomial Infections (GEIH).

J Clin Microbiol. 2010 Aug;48(8):2840-5. doi: 10.1128/JCM.02147-09. Epub 2010 Jun 2.

PMID:
20519460
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.

Oteo J, Diestra K, Juan C, Bautista V, Novais A, Pérez-Vázquez M, Moyá B, Miró E, Coque TM, Oliver A, Cantón R, Navarro F, Campos J; Spanish Network in Infectious Pathology Project (REIPI).

Int J Antimicrob Agents. 2009 Aug;34(2):173-6. doi: 10.1016/j.ijantimicag.2009.03.006. Epub 2009 May 22. Erratum in: Int J Antimicrob Agents. 2010 Nov;36(5):483.

PMID:
19464856
[PubMed - indexed for MEDLINE]
15.

Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.

Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.

J Korean Med Sci. 2013 Jul;28(7):998-1004. doi: 10.3346/jkms.2013.28.7.998. Epub 2013 Jul 3.

PMID:
23853481
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.

Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD.

Antimicrob Agents Chemother. 2010 Mar;54(3):1327-30. doi: 10.1128/AAC.01338-09. Epub 2010 Jan 4.

PMID:
20047913
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH; Coli β Study Group.

J Clin Microbiol. 2012 Sep;50(9):2974-81. Epub 2012 Jul 3.

PMID:
22760036
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.

Kuroda H, Yano H, Hirakata Y, Arai K, Endo S, Kanamori H, Yamamoto H, Ichimura S, Ogawa M, Shimojima M, Komatsu M, Jonai T, Itagaki S, Nonomiya Y, Suwabe A, Kaku M.

Diagn Microbiol Infect Dis. 2012 Oct;74(2):201-3. doi: 10.1016/j.diagmicrobio.2012.06.011. Epub 2012 Jul 12.

PMID:
22796185
[PubMed - indexed for MEDLINE]
19.

Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.

Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y.

J Antimicrob Chemother. 2009 Jan;63(1):72-9. doi: 10.1093/jac/dkn463. Epub 2008 Nov 11.

PMID:
19004839
[PubMed - indexed for MEDLINE]
Free Article
20.

Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.

Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH; Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).

J Antimicrob Chemother. 2010 Mar;65(3):465-9. doi: 10.1093/jac/dkp471. Epub 2010 Jan 6.

PMID:
20053690
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk